Hirsch Andrew — SEC Form 4 filings
SEC reporting owner CIK 1586707. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-15 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | President & CEO, Director | 6 | — | — | 18 |
| Editas Medicine, Inc. (EDIT) | Director | 3 | — | — | 3 |
Form 4 filings — Hirsch Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 51,700 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 700,000 @ $0 · Option exercise (M): 81,725 @ $0 · Tax withholding (F): 39,154 @ $1.89 · Option exercise (M): 20,400 @ $0 · Tax withholding (F): 9,057 @ $1.89 | EDGAR |
| 2025-06-10 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 223,500 @ $0 · Tax withholding (F): 12,847 @ $3.18 · Tax withholding (F): 9,370 @ $3.18 · Grant/award (A): 335,300 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 12,500 · Tax withholding (F): 5,550 @ $6.04 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 7,500 · Tax withholding (F): 3,329 @ $6.36 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 103,400 @ $0 · Grant/award (A): 465,500 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 6,560 @ $7.90 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1586707 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →